What Conditions Might Elevated Serum Ferritin Indicate?

Serum ferritin elevation is not a disease in itself but rather a laboratory finding that signals underlying physiological or pathological processes. Ferritin, the primary intracellular iron storage protein, circulates in low concentrations in serum and serves as the most sensitive and specific biomarker for total body iron stores. Elevated serum ferritin—typically defined as >300 µg/L in men and >200 µg/L in women—can reflect iron overload, but more commonly indicates an acute-phase reactant response to inflammation, infection, liver disease, or malignancy.

Hereditary hemochromatosis remains the classic cause of true iron overload, particularly in individuals of Northern European descent with HFE gene mutations (e.g., C282Y homozygosity). In such cases, persistently high ferritin—often accompanied by elevated transferrin saturation (>45%)—may precede clinical manifestations like cirrhosis, diabetes mellitus, cardiomyopathy, or hypogonadism. However, isolated hyperferritinemia without iron overload is far more prevalent and frequently associated with metabolic dysfunction–associated steatotic liver disease (MASLD), chronic viral hepatitis, alcoholic liver disease, or nonalcoholic fatty liver disease (NAFLD).

Importantly, ferritin is a positive acute-phase protein: levels rise in response to cytokines such as interleukin-6 during systemic inflammation, sepsis, autoimmune disorders (e.g., rheumatoid arthritis, adult-onset Still disease), or even severe obesity. Malignancies—including lymphomas, leukemias, and hepatocellular carcinoma—can also drive marked ferritin elevation, sometimes serving as a prognostic indicator of tumor burden or aggressive disease biology.

Clinical interpretation requires careful correlation with additional testing: serum iron, total iron-binding capacity (TIBC), transferrin saturation, C-reactive protein (CRP), liver enzymes, and imaging when indicated. In the absence of overt inflammation or liver disease, genetic testing for hemochromatosis or quantitative liver iron concentration via MRI may be warranted. Management hinges on identifying and treating the root cause—whether phlebotomy for iron overload, anti-inflammatory therapy for autoimmune conditions, or oncologic intervention—rather than targeting ferritin itself.